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Abstract Four years after disclosure of the full yeast genome
sequence, a series of resources including tens of thousands of
mutant strains, plasmids bearing isolated genes and disruption
cassettes are becoming publicly available. Deletions of each of
the 6000 putative yeast genes are being screened systematically
for dozens of phenotypic traits. In addition, new global
approaches such as DNA hybridization arrays, quantitative
proteomics and two-hybrid interactions are being steadily
improved. They progressively build up an immense computation
network of billions of data points which will, within the next
decade, characterize all molecular interactions occurring in a
simple eukaryotic cell. In this process of acquisition of new basic
knowledge, an international community of over 1000 laboratories
cooperates with a remarkable willingness to share projects and
results. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The ¢rst chromosome ever sequenced was yeast chromo-
some III, published in 1992 (Table 1). Between 1994 and
1996, all 15 other yeast chromosomes were completed and
made public by 16 di¡erent teams of the international com-
munity of ‘yeast scientists’. This series was only interrupted in
mid-1995 by the publication of the bacterial chromosomes
from Haemophilus in£uenzae and Mycoplasma genitalia, both
sequenced by TIGR. The total yeast genome was put on the
web by MIPS (Munich information center for protein sequen-
ces) in a fully organized and annotated form, on 24 April
1996. This is, the ¢rst, and possibly still the only case where
fully organized and annotated genome data (and not just the
raw sequences of the day) were made public well before the
‘Lords of Publication’ gave their o⁄cial imprimatur. In this
respect, the yeast genome has pioneered the new trendy policy
of ‘publication on the web’.
A remarkable feature of the yeast genome data is the use of
a non-ambiguous and non-redundant nomenclature for open
reading frames (ORFs), proteins and genes, well curated by
three complementary databases: MIPS (http://www.mips.
biochem.mpg.de), SGD (http://genome-www.stanford.edu)
and YPD (http://www.proteome.com). However, the total
numbers of ORFs encoded by the yeast genome, and the exact
number of ORFs of unknown function are still uncertain.
For instance, on 15 May 2000, the yeast genome was esti-
mated by YPD to encode 6149 putative proteins of which
4270 are characterized by genetics, biochemistry or sequence
homology. On the same date and according to MIPS, the
genome contains 6368 ORFs of which 178 correspond to
small proteins of less than 100 amino acids, most of which
were identi¢ed by the SAGE technique [26]. MIPS estimates
that a total of 4344 ORFs are known by genetics, biochemis-
try or homology.
Stanislaw Cebrat et al. (Wroclaw, Poland) estimate on the
basis of codon usage in the second position that up to 1200
‘unknown’ ORFs could be non-coding [27]. Most of them
would correspond to overlapping antisense ORFs which
were replicated independently of their sense partner during
evolution. In contrast, MIPS lists only 447 ‘questionable’
ORFs unlikely to be expressed.
In brief, because of di¡erent de¢nitions of ‘unknown’ or
‘hypothetical’ and ‘uncoding’ or ‘questionable’ ORFs, the
number of yeast proteins of which the function remains to
be identi¢ed is estimated to be 300 (the Cebrat ‘uncoding’)
or 1568 (the MIPS ‘hypothetical’) or 1879 (the YPD ‘un-
known’).
An important complement of the yeast genome was the
sequencing of the mitochondrial DNA from the strain S288c
which had also been used for nuclear genome sequencing [25].
Yeast mitochondrial DNA is highly polymorphic and before
its sequencing by Franc°oise Foury (Louvain-la-Neuve, Bel-
gium) only a virtual and incomplete assembly of mitochon-
drial DNA from di¡erent strains was available [28]. The ¢nal
version of mtDNA unraveled more than 10 kb of new mito-
chondrial DNA with seven small putative ORFs probably not
coding. It also identi¢ed three hotspots of point mutations in
the exons bordering group I intron-related sequences. The
mtDNA sequence also allowed Bernard Dujon (Pasteur,
France) to identify 34 mitochondrial DNA fragments (22^
230 bp in length) inserted, probably by double strand break
repair, in the non-coding sequence of the nuclear genome [29].
During the last 4 years, a large scienti¢c community, esti-
mated to amount to at least 5000 scientists in more than 1000
laboratories, has published nearly 7000 papers on yeast genes
and genomics (Jim Garrel and Peter Hodges, Proteome, per-
sonal communication). Approximately 60% of these laborato-
ries are located in the USA and about 35% are in Europe. In
those 4 years the full yeast community has deciphered exper-
imentally the biochemical or physiological function of 1060
yeast proteins which were unknown in 1996 (see YPD). This
community also set up a series of large-scale resources which
all are publicly available.
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2. Deletion mutant libraries
The e⁄cient homologous DNA recombination in yeast cells
has allowed the construction of several massive deletion mu-
tant libraries. The EUROFAN project deleted and grossly
characterized the mutant phenotypes from 758 ORFs of un-
known function among the 4400 ORFs (71% of the total
genome) initially sequenced by the European laboratories
(see MIPS/EUROFAN). The same procedure was used by
the German Yeast Network which deleted 322 genes in several
strains [30]. The ‘mass murder’ project organized by Bernard
Dujon has analyzed 129 overlapping large deletions from
chromosome XI covering a total of 217 ORFs [31]. Systematic
deletions of chromosome III by Piotr Slonimski (Gif sur
Yvette, France) and VIII by Johannes Hegemann (Giessen,
Germany) were also carried out [32,33]. The most ambitious
project, called ‘Transatlantic Consortium for Bar-Coded De-
letion’, which aims at deleting all the 6000 yeast genes, is near
completion. Each deletant is marked by unique 20-mer
nucleotide signatures which allows recognition under selective
conditions [34]. Deletants, plasmids containing individual
genes and disruptant cassettes are available at EUROSCARF
(http://www.uni-frankfurt.de/FB/mikro/euroscarf/index-htlm)
or RESEARCH GENETICS (http://www.resgen.com).
Among the 3662 deleted ORFs tested so far, only 884 are
presently recorded as being essential for cell growth (see
MIPS). They include 42 ‘hypothetical’ proteins (with no sim-
ilarity) and curiously, 15 ‘questionable’ proteins (which are
considered unlikely to be expressed).
The 758 EUROFAN deletants are presently being screened
systematically by more than 100 European laboratories under
the scienti¢c general coordination of Steve Oliver (Manches-
ter, UK) and originally that of Peter Philippsen (Basel, Swit-
zerland). A series of phenotypes are examined systematically,
such as growth, temperature, resistance to metal ions, to high
osmotic pressure, to ethanol, to antibiotics and other drugs,
meiosis, recombination repair, telomeric structure, transport,
organelles, lipids, secretion, tra⁄cking, cytoskeleton, cell wall,
morphogenesis, sporulation, stationary phase recovery, mat-
ing, genetic redundancy. The systematic search of lethal code-
letants of certain ORFs is proceeding. This work should be
completed and made public before the end of the year 2000. It
will produce tens of thousands of data points and is expected
to identify several hundreds of new phenotypes. Preliminary
data can be consulted at the MIPS web site.
3. The transposon insertion mutant library
Early projects obtained a limited number of mutants inter-
rupted by yeast Ty1 [35] or bacterial mini Mu [36] transpo-
sons. More recently, Michael Snyder and collaborators [37]
have generated randomly, by insertion of a bacterial trans-
poson, nearly 7800 yeast mutants. Many of these mutants
have been characterized for level of expression (using a trans-
poson-encoded lacZ reporter), as well as for 27 di¡erent phe-
notypes such as growth, temperature sensitivity, sensitivity to
chemicals (by large-scale macroarray analysis), and for 19 the
subcellular localization has been determined (using FGP or
HA epitope). A total of 250 000 data points were provided
by preliminary screenings of aliquots of the mutant library.
For example, this approach has unraveled the involvement in
sporulation of seven genes previously not known and 15 pre-
Table 1
The ¢rst yeast and bacterial chromosome sequences
Chromosome Length (in kb) Coordinator Public availability Ref.
S. cerevisiae III 315 S. Oliver (UK) March 1992 [1]
S. cerevisiae XI 666 B. Dujon (France) June 1994 [2]
S. cerevisiae VIII 589+CUP1 M. Johnston (USA) September 1994 [3]
S. cerevisiae II 813 H. Feldmann (Germany) December 1994 [4]
S. cerevisiae I 230 H. Bussey (Canada) April 1995 [5]
S. cerevisiae VI 271 Y. Murakami (Japan) July 1995 [6]
H. in£uenzae 1850 R. Fleischmann, C. Venter (USA) July 1995 [7]
M. genitalium 471 C. Fraser, C. Venter (USA) October 1995 [8]
S. cerevisiae Total genome (web) 13 478 W. Mewes, J. Sgouros, K. Kleine, J.
Hani, A. Zollner (MIPS, Germany),
M. Cherry (SGD, USA)
April 1996 [9]
S. cerevisiae X 745 F. Galibert (France) June 1996 [10]
M. jannaschii 1660 C. Bult, C. Venter (USA) August 1996 [11]
S. cerevisiae Total genome (paper) 13 478 A. Go¡eau (Belgium) October 1996 [12]
M. pneumoniae 816 R. Himmelreich (Germany) November 1996 [13]
Synechocystis 3573 T. Kaneko, S. Tabata (Japan) November 1996 [14]
S. cerevisiae Genome directory A. Go¡eau and 641 others (Europe,
USA, Japan, Canada)
May 1997 [15]
S. cerevisiae IV 1532+PMR2 C. Jacq (France) May 1997 [16]
S. cerevisiae V 577 F. Dietrich (USA) May 1997 [17]
S. cerevisiae VII 1091 H. Tettelin (Belgium) May 1997 [18]
S. cerevisiae IX 440 B. Barrell (UK) May 1997 [19]
S. cerevisiae XII 1078+1 Mb rDNA M. Johnston (USA), J. Hoheisel
(Germany)
May 1997 [20]
S. cerevisiae XIII 924 B. Barrell (UK) May 1997 [21]
S. cerevisiae XIV 784 P. Philippsen (Switzerland) May 1997 [22]
S. cerevisiae XV 1091 B. Dujon (France) May 1997 [23]
S. cerevisiae XVI 948 H. Bussey (Canada), B. Barrell (UK),
K. Davis (USA), M. Johnston (USA),
A. Go¡eau (Belgium)
May 1997 [24]
S. cerevisiae mtDNA 86 F. Foury (Belgium) December 1998 [25]
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viously uncharacterized genes. All constructions are freely
available from on-line order (http://fondue.med.yale.edu/
ygac/triples.htm).
4. DNA hybridization arrays
New global approaches aimed at characterization of a large
number of genes by screening the full yeast genome have been
developed these last 4 years. The most popular one is the
DNA hybridization array on glass slides or membranes which
probes simultaneously the mRNA level of all yeast genes
under speci¢c genetic and physiological conditions. The data
output of such analyses is fabulous: 6000 mRNA levels per
chip per week. Important biological parameters have already
been tested, such as diauxy, cell cycle, meiosis, sporulation,
ploidy, rich versus minimal medium, mitogen-activated pro-
tein kinases and other mutants, salt stress, osmotic stress, oxi-
dative and chemical stresses, deletion, overexpression or acti-
vation of transcription factors (TUP1, YAP1, PDR1, PDR3).
Very recently, up to 300 complete expression pro¢les were
generated in which transcript levels of 287 mutants and 13
compound-treated cultures were analyzed [38]. An immense
wealth of data of over 1 billion data points has already
been obtained which is impossible to summarize here (see
http://www.biologie.ens.fr/yeast-publi.html for references and
links).
The following rules emerge. The present method seems very
simple. A do-it-yourself protocol is on the web (http://emgm.
stanford.edu/pbrown/mguide/index.html). In reality, consider-
able time and skills are required for mastering the numerous
experimental parameters modulating the data. Even so, the
method is of limited sensitivity; only ratios between sample
and control above 2 are considered signi¢cant. Small-magni-
tude £uctuations in transcript abundance were analyzed in a
series of 63 seemingly identical cultures [38]. These £uctua-
tions are believed to represent a form of biological noise
due to the regulation of several sets of genes by nutritional
or stress factors. They account for virtually all the transcrip-
tional changes when two conditions are compared which do
not modify the growth rate [38]. Careful design of some of the
DNA probes is necessary to avoid cross-hybridization by
mRNAs from highly similar genes (e.g. the large HXT family
of glucose transporters). The level of mRNA often varies con-
siderably within minutes after setting up a given physiological
condition. In these cases, a kinetic analysis is required. Only
two arrays of the yeast genome are commercially available:
the Research Genetics membranes and the A¡ymetrics chips.
Neither covers the complete yeast genome unambiguously.
Their current price is out of reach of most laboratories since
measurements should in principle be reproduced in three dis-
tinct experiments with at least three time points each. These
and other pitfalls are expected to be solved in the future [39].
Still, the DNA array approach already provides valid data
because large di¡erences in expression pro¢les are generally
analyzed. As a safe rule, the major conclusions should be
con¢rmed by other methods such as Northern, lacZ fusion,
proteomic or biochemical measurements. In this respect, the
near availability of transcript quanti¢cations of about 1000
yeast ORFs by Northern analysis under eight physiological
conditions (glucose regulation, nitrogen starvation, stationary
phase and various stresses) organized by Rudi Planta (Am-
sterdam, The Netherlands) and Alistair Brown (Aberdeen,
UK) within the EUROFAN project (see MIPS/EUROFAN)
will provide useful reference points for the other DNA array
data. Despite the present shortcomings of the technique, it is
not di⁄cult to predict that within a few years, thousands of
yeast microarray analyses will become available. An immense
network of data reporting the mRNA levels of all yeast genes
in numerous physiological and genetic conditions is building
up which will be manageable only by informatic network soft-
ware presently under development. It is likely that most of the
data will be published only on the web.
5. Proteome
The mRNA level is not always related to the level of active
protein. Therefore, the proteome analysis has to be developed.
The proteome has been de¢ned by the Australians Marc Wil-
kins and Keith Williams et al. [40] as the set of proteins from
a given cell, tissue or species identi¢ed by two-dimensional
electrophoresis. Unfortunately, the integral membrane or
small proteins cannot be separated by current techniques
and the method requires at least one femtomol of each ana-
lyzed protein. Often, tryptic digestion has to be carried out.
Their mass can only be identi¢ed in proteomes from fully
sequenced genomes. These limitations explain why only about
2000 yeast protein spots can be analyzed today in total cell
extracts. Among those, less than 300 yeast proteins (http://
www.ibgc.u-bordeaux2.fr/ypm) have been identi¢ed by mass
spectroscopy or other methods [41]. A recent important im-
provement has been the commercial availability of immobi-
lized pH gradient gels as support of the ¢rst dimension elec-
trophoresis which allows data to be highly reproducible from
one laboratory to another [42]. Here again, yeast, because of
its simplicity and the exhaustive exploration of its genome and
transcriptome, is the test-bed of choice for the development of
the proteome technique.
Among others, the following parameters have been recently
analyzed at the proteome level : oxidative stress [43], cyclic
AMP mutants [44], and multidrug-resistant mutants [45].
The latter analysis is the ¢rst one where DNA microarray
[46] and proteome data could be compared under exactly
identical genetic and physiological conditions. The following
conclusions could be drawn. The proteome analysis is more
cumbersome and requires more heavy equipment and know-
how than the DNA hybridization analysis. However, it seems
to be more reproducible. Di¡erences of the order of 30%
between the level of given protein spots assessed in di¡erent
conditions can be signi¢cant at the 99% probability level,
when the average of three independent cultures is used for
each measurement [45]. The metabolic and physiological con-
sequences of a 30% increase or decrease in an enzyme level
can be quite signi¢cant. The proteome data on multiple drug
resistance determinants overlap only partly with the DNA
microarray data. This results from the greater relative sensi-
tivity of the proteome approach which makes it possible to
pinpoint ¢ne-tuning regulations of protein synthesis which
escape the DNA microarray approach. Also, protein post-
translation modi¢cations (proteolysis, phosphorylation and
others) are detected.
In brief, next to biochemical activity measurements which
rarely can be carried out on a large scale, the proteome anal-
ysis is the method of choice for global investigations of ¢ne-
tuning of metabolic pathways induced by physiological or
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genetic parameters. Watch, however, the ¢rst attempt of ge-
nomic-scale biochemical screening [47] based on construction
of glutathione S-transferase fusion ORFs puri¢ed and tested
in de¢ned pools. Once more, yeast is the test-bed of choice for
future development and very soon an immense network of
proteome and biochemical data, probably physiologically
more meaningful than those provided by DNA microarray,
will be available on the web.
6. Two-hybrid analysis
This ingenious method aims at the identi¢cation of protein^
protein physical interactions by coexpression in the same cell
[48]. Saccharomyces cerevisiae has been found to be the best
host for such an approach, which however remains inappro-
priate for membrane-bound proteins. Three large-scale analy-
ses have been carried out on yeast proteins. None of them has
yet analyzed all possible 36 million combinations among all
proteins of S. cerevisiae. Ito et al. [49] have tested 4 million
di¡erent combinations (11% of the total) which revealed 183
independent two-hybrid interactions. In particular, this set of
data revealed new putative connections between distinct steps
of vesicular transport. Uetz et al. [50] have tested 1.2 million
interactions (3% of the total) and identi¢ed 48 possible part-
ners. In particular, new interactions in arginine metabolism, in
the regulation of the cell cycle and generation of the meiotic
synaptonemal complex were unraveled. Fromont-Racine et al.
[51] have further re¢ned the method. A library of 3 million
fragments with an average of nearly 250 amino acids was
tested iteratively as prey for interaction with a subset of the
6000 full yeast gene products as bait. In a ¢rst screening
against 150 full yeast gene products (2.5% of the genome),
more than 1000 di¡erent ORFs were found to interact (P.
Legrain, this issue). In particular, a role for a new complex
involved on the one hand in the nuclear spliceosome and on
the other hand in the cytoplasmic degradation of mRNA has
been unraveled.
In brief, even though two-hybrid analysis of the full yeast
genome remains a herculean task, there is no doubt that it is
well under way and that the data output is accelerating. Here
again the identi¢ed interactions must be regarded as putative
and be con¢rmed by other methods such as cross-linking,
coimmunoprecipitation, a⁄nity column, copuri¢cation, etc.
Using these methods, a total of more than 2000 protein^pro-
tein interactions are listed by YPD.
7. Other yeast genomes
Before the end of the year 2000, it is expected that the
genome of the ¢ssion yeast Schizosaccharomyces pombe
(http://www.sanger.ac.uk/Projects/S-pombe) will be com-
pleted. Interestingly, it seems that as much as 30% of the
two genomes di¡er. Also, the genome of the pathogenic yeast
Candida albicans is already largely covered by shotgun se-
quencing (http://www.stanford.edu/group/candida). This will
circumvent the locking of the pharmaceutical companies
which have privileged access to private genome data and
hope to bene¢t from a small time lead in the development
of new antifungals. The 8.8 Mb genome sequence of the cot-
ton pathogen Achbya is near completion by Fred Dietrich and
Peter Philippsen (Basel, Switzerland).
Finally, a French consortium coordinated by Jean-Luc Sou-
ciet (Strasbourg, France) has shot-gunned 14 Hemiascomycete
genomes from species closely related to S. cerevisiae. A low
coverage sequence of each genome has been achieved which
provides information on a total of 22 000 genes from these
newly analyzed yeast species. A wealth of data on the recent
evolution of yeast species and on possible pathogenic or in-
dustrial gene products has been accumulated and will be de-
scribed in a forthcoming issue of FEBS Letters.
8. Conclusion
Less than a decade ago, the full molecular description of
any eukaryotic cell seemed unreachable. With the complete
genome sequence of S. cerevisiae, a ¢nite number of about
6000 genes was shown to be su⁄cient for encoding all the
proteins from an eukaryotic cell. The large scienti¢c commun-
ity studying yeast, combined with the relative simplicity of the
cell, its unique physiological and genetic assets, the emergence
of powerful global tools such as DNA hybridization arrays,
proteomics and two-hybrid interaction analyses should rap-
idly make available millions of new biological data points.
Within the next decade, the yeast cell, this humble servant
of mankind, will be upgraded to the status of the ¢rst eukary-
otic cell from which informatic boolean networks will compile
all molecular interactions between genes and gene products
and all metabolic £uxes in hundreds of di¡erent physiological
conditions.
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